Bruker Appoints Bernd Gewiese and Werner Maas as Co-Presidents of its Bruker BioSpin Division
16 November 2009 - 11:00PM
Business Wire
Bruker Corporation (NASDAQ: BRKR) today announced that it has
appointed Dr. Bernd Gewiese and Dr. Werner Maas as Co-Presidents of
its Bruker BioSpin division, with an effective date of February
1st, 2010. Presently, both are serving as Executive Vice Presidents
of Bruker BioSpin.
Frank Laukien, Bruker’s President and CEO, commented: “As Bruker
approaches its 50th anniversary, its Bruker BioSpin division today
is the global technology and market leader in NMR, EPR and
pre-clinical MRI. The appointment of Drs. Bernd Gewiese and Werner
Maas as division Co-Presidents signifies a continuation of Bruker
BioSpin’s unmatched commitment to ‘innovation for customers,
delivered with integrity’. With a strong focus on operational
excellence and continued investment in exciting new technologies
and growth opportunities, Bruker is looking forward to a bright
future of its magnetic resonance business.”
Biographies
Dr. Bernd Gewiese received his Ph.D. for in vivo NMR/MRI from
the Technical University of Berlin, Germany. He joined Bruker in
1992 as MRI product manager, after five years of scientific work in
MRI at the Steglitz Klinikum of the Free University of Berlin. In
1999, he was appointed as managing director of Bruker BioSpin MRI
GmbH, and in 2005 he was appointed as Executive Vice President of
Bruker BioSpin MRI. In 2007, Dr. Gewiese took over the management
of Bruker BioSpin GmbH in Germany, and also was appointed as
Executive Vice President of the Bruker BioSpin division.
Dr. Werner Maas obtained a Ph.D. in solid-state NMR from
the University of Nijmegen in The Netherlands. He joined Bruker in
1992 as a Postdoctoral Fellow in the US, and stayed on as a
Research Scientist. In 2001, he was appointed as Vice President for
R&D, and in 2005 he also became Vice President for MRI in the
US. In 2007, Dr. Maas was appointed as Executive Vice President of
the Bruker BioSpin division.
ABOUT BRUKER CORPORATION
Bruker Corporation is a leading provider of high-performance
scientific instruments and solutions for molecular and materials
research, as well as for industrial and applied analysis. For more
information about Bruker Corporation, please visit
www.bruker.com.
CAUTIONARY STATEMENT
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to risks and
uncertainties, that could cause actual future results to differ
materially from those projected including, but are not limited to,
risks and uncertainties relating to adverse changes in conditions
in the global economy and volatility in the capital markets, the
integration of businesses we have acquired or may acquire in the
future, changing technologies, product development and market
acceptance of our products, the cost and pricing of our products,
manufacturing, competition, dependence on collaborative partners
and key suppliers, capital spending and government funding
policies, changes in governmental regulations, realization of
anticipated benefits from economic stimulus programs, intellectual
property rights, litigation, and exposure to foreign currency
fluctuations and other risk factors discussed from time to time in
our filings with the Securities and Exchange Commission. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our recent
Proxy Statements on Schedule 14A, our annual report on Form 10-K
for the year ended December 31, 2008, our most recent quarterly
reports on Form 10-Q and our current reports on Form 8-K. We
expressly disclaim any intent or obligation to update these
forward-looking statements other than as required by law.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024